As science and technology continue to advance, so does the potential to revolutionise healthcare, and Advanced Therapies Integrates 2022 provided a platform to discuss the most cutting-edge field in medicine.
3 questions with…
BRIAN MULLAN
Chief Technical Officer, Cell and Gene Therapies
Yposkesi
Nanoform, an innovative nanoparticle medicine enabling company, together with TargTex, a European biotech company, will present highly promising in-vivo data, enabled by nanoformed drug product for the treatment of Glioblastoma.
3 questions with…
FREDDIE DEAR
Head of Corporate Development & Portfolio Manager
Ascend Gene and Cell Therapies
We are delighted to share the news that CPI’s RNA Centre for Excellence and Training Academy.is now open. We announced today that it has been funded by an additional £10.65 million investment from the UK Government’s Vaccine Taskforce. This first-of-its-kind Centre will support the development, scale-up and manufacture of new RNA therapies and vaccines. The RNA Training Academy will upskill scientists to support the soaring global demand for RNA-based vaccines and therapeutics.